HSE has conducted a review of the approval of the active substance mancozeb and proposes to
withdraw the approval of the active substance in Great Britain.

• HSE has reviewed the approval of mancozeb under Article 21 of retained Regulation (EC)
1107/2009, a process by which HSE may initiate a review of any aspect of the approval of a
pesticide active substance at any point in light of new scientific information which indicates
that it may no longer satisfy the criteria for approval.

• This review considered the evidence for continuing approval of mancozeb, including
supporting data submitted by UPL Europe Ltd and Indofil Industries (Netherlands) BV (being
the EU Mancozeb Task Force).

• HSE concluded that mancozeb does not meet the approval criteria and HSE therefore
proposes to withdraw the approval of mancozeb in Great Britain (GB).

• Approval of the active substance mancozeb (current expiry 31st January 2024) will be
extended, most likely for an interim period of 3 months (to be confirmed).

• Withdrawal periods for approved products containing mancozeb are yet to be confirmed by
HSE. UPL Europe Ltd and Indofil Industries (Netherlands) BV will advise our customers as
soon as this information is available.

UPL Europe Ltd and Indofil Industries Netherlands BV fully appreciate the importance of mancozeb
for the control of potato blight, in particular its multi-site activity for resistance management. We
will therefore work closely with global and UK stakeholders and the UK authorities to evaluate
what options are available to maintain the availability of mancozeb products in the UK.